Bioorganic and Medicinal Chemistry Letters p. 887 - 892 (1997)
Update date:2022-08-02
Topics:
Martin, Michael J.
Grese, Timothy A.
Glasebrook, Andrew L.
Matsumoto, Ken
Pennington, Lewis D.
Phillips, D. Lynn
Short, Lorri L.
Methodology has been employed that permits the differentiation of the phenols of raloxifene. Transition metal mediated transformations of raloxifene triflates have subsequently provided a number of analogs that were evaluated further in two in vitro models predictive of estrogen receptor mediated biological activity.
View MoreShanghai Coupling Pharmaceutical R&D Co., Ltd.(expird)
Contact:+86 021 50106671
Address:403 Room No.4 Buiding, No. 526 Ruiqing Road, Shanghai Zhangjiang Hi-Tech Park
Suzhou Chenke Biotech Co., Ltd.
Contact:+86-18662408853
Address:NO.150, Renai Road, Suzhou Industrial Park
Contact:+86-27-87204219, +86-27-87215023
Address:2402, HuiGu Space-time Building, 8 Forest Road, East Lake Hi-Tech Development Zone
Shenzhen Feiming Science and Technology Co,. Ltd
Contact:+86-755-85232577
Address:#B2309, Fenglin International Center ,Jixiang Road, Longcheng street, LongGang District, Shenzhen city, Guangdong province, China.
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
Doi:10.1002/1521-3773(20021104)41:21<4093::AID-ANIE4093>3.0.CO;2-I
(2002)Doi:10.1016/j.tet.2011.05.131
(2011)Doi:10.1002/hlca.19730560609
(1973)Doi:10.1002/jhet.5570440511
(2007)Doi:10.1246/bcsj.20120314
(2013)Doi:10.1016/j.bmcl.2005.03.070
(2005)
